Detection of biomarkers from exhaled breath
US11397177B2 · kind B2 · utility
0Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 13, 2020 |
| Grant date | Jul 26, 2022 |
| Priority date | — |
| Expiry date | Jun 11, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2021/1704
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The technology relates to devices and methods thereof for the detection of one or more biomarkers from a user's exhaled breath. In one embodiment, the present invention provides a device comprising a metered dose inhaler, and a sensor that detects one or more biomarkers comprising HFA, CO2, and NO. In another embodiment, the device detects HFA, CO2 and NO simultaneously by photoacoustic spectroscopy. In another embodiment, the device may be used as part of an overall treatment regimen for asthma or COPD.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.